Finally, to further evaluate the influence of complement activation on STEC-HUS patient's clinical conditions and outcomes, all patients were assigned to two groups according to the baseline serum levels of C3 above or below the cut-off value found in the whole study group (0.765 g/L). Here, C3 is linked to hemolytic-uremic syndrome.